
    
      The overall purpose of the study is to evaluate the biodistribution and target lesion uptake
      of 89Zr-KN035 in patients with PD-L1 positive advanced solid tumors by using PET imaging.
      Safety will be observed after 89Zr-KN035 injection, and radiation dosimetry of 89Zr-KN035
      will be calculated.
    
  